Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity.
D000367:Age Factors; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001812:Blood-Brain Barrier / Q000187:drug effects* / Q000378:metabolism; D001921:Brain / Q000201:enzymology / Q000378:metabolism; D002196:Capillaries / Q000187:drug effects / Q000201:enzymology / Q000503:physiopathology; D002800:Cholinesterase Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D002802:Cholinesterases / Q000032:analysis / Q000378:metabolism; D004347:Drug Interactions; D006735:Horseradish Peroxidase / Q000008:administration & dosage / Q000032:analysis; D006801:Humans; D007306:Insecticides / Q000633:toxicity*; D008297:Male; D010261:Paraoxon / Q000037:antagonists & inhibitors / Q000633:toxicity*; D018923:Persian Gulf Syndrome / Q000209:etiology / Q000378:metabolism; D011729:Pyridostigmine Bromide / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D020318:Rats, Long-Evans
D002800:Cholinesterase Inhibitors; D007306:Insecticides; D006735:Horseradish Peroxidase; D002802:Cholinesterases; D011729:Pyridostigmine Bromide; D010261:Paraoxon